Reuters logo
BRIEF-Teva Pharmaceuticals receives warning letter from the FDA
October 18, 2016 / 1:21 PM / a year ago

BRIEF-Teva Pharmaceuticals receives warning letter from the FDA

Oct 18 (Reuters) - Teva Pharmaceutical Industries Ltd -

* On october 14, 2016, received a warning letter from the U.S. Food and Drug Administration

* Warning letter is connected with an FDA Current Good Manufacturing Practices (CGMP) inspection of the company’s godollo manufacturing facility

* FDA letter cites deficiencies in manufacturing operations and laboratory controls, and in the company’s data integrity program

* Undertaken corrective actions to address both specific concerns raised by investigators and underlying causes of those concerns

* FDA inspection of co's godollo manufacturing facility conducted from Jan 21, 2016 through Jan 29, 2016 Source text: bit.ly/2egOFZC Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below